CVS Health Corporation $CVS Shares Sold by apricus wealth LLC

apricus wealth LLC lowered its holdings in CVS Health Corporation (NYSE:CVS) by 90.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,135 shares of the pharmacy operator’s stock after selling 39,325 shares during the period. apricus wealth LLC’s holdings in CVS Health were worth $328,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Harbor Capital Advisors Inc. raised its position in shares of CVS Health by 72.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 142 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its position in shares of CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 281 shares in the last quarter. Corundum Trust Company INC bought a new stake in shares of CVS Health in the third quarter worth $29,000. Front Row Advisors LLC increased its stake in shares of CVS Health by 436.5% in the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 371 shares during the last quarter. Finally, GoalVest Advisory LLC acquired a new stake in CVS Health in the fourth quarter valued at $32,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have weighed in on CVS. Mizuho raised their price objective on shares of CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, December 10th. Leerink Partners restated an “outperform” rating and issued a $98.00 target price on shares of CVS Health in a research note on Thursday, March 5th. UBS Group reaffirmed an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Robert W. Baird boosted their price objective on CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. Finally, Truist Financial set a $100.00 price objective on CVS Health in a research note on Wednesday, December 10th. Twenty equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $95.05.

CVS Health Stock Down 0.1%

CVS stock opened at $69.98 on Tuesday. The firm has a market cap of $89.02 billion, a price-to-earnings ratio of 50.71, a PEG ratio of 0.73 and a beta of 0.49. CVS Health Corporation has a 1-year low of $58.35 and a 1-year high of $85.15. The firm has a fifty day moving average price of $76.45 and a two-hundred day moving average price of $77.76. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The company had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. During the same period last year, the firm posted $1.19 EPS. The company’s revenue for the quarter was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Research analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.8%. The ex-dividend date is Thursday, April 23rd. CVS Health’s payout ratio is presently 192.75%.

More CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS plans to expand its retail footprint with ~60 new store openings this year, including 20 small pharmacy‑only sites and Target-based locations — a reversal after years of downsizing that could lift pharmacy revenues and local market access over time. CVS to Grow Store Footprint This Year With 60 New Locations
• Positive Sentiment: CVS opened its first pharmacy‑only, apothecary‑style location in Chicago and says it will open nearly 20 such small neighborhood pharmacies this year — a push to increase access to meds, immunizations and pharmacist services that can boost prescription volumes and convenience-driven traffic. CVS Pharmacy® celebrates opening of first pharmacy-only location in Chicago
• Positive Sentiment: Industry research highlights growth in the chemotherapy‑at‑home market and lists CVS among market leaders — an expanding, higher‑margin services opportunity that could drive longer‑term revenue diversification beyond retail prescriptions. Trends and Opportunities in the Chemotherapy-At-Home Services Market
• Neutral Sentiment: State-level policy developments in Tennessee could affect local store economics but remain uncertain — some reporting says reform language might allow CVS to keep pharmacies open, which is a mixed operational signal for investors. CVS could keep pharmacies open under Tennessee reform bill, local pharmacists say
• Negative Sentiment: CVS reached a proposed FTC settlement related to insulin pricing; the company says the process should conclude in coming weeks. That regulatory overhang introduces potential remediation costs, fines or operational limits that can weigh on near‑term sentiment and multiples. CVS Health (CVS) Reaches Proposed FTC Settlement on Insulin Pricing
• Negative Sentiment: Local reporting and opinion pieces highlight threats or disputes around potential pharmacy closures in Tennessee — a reminder of operational, regulatory and community‑relations risks that can amplify short‑term negative sentiment. The real reason CVS is threatening to close TN pharmacies | Letters

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.